Corteva (NYSE:CTVA) Hits New 12-Month High – Here’s What Happened

Corteva, Inc. (NYSE:CTVA) reached a new 52-week high during trading on Tuesday . The company traded as high as $86.51 and last traded at $86.3380, with a volume of 4132556 shares changing hands. The stock had previously closed at $85.80.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CTVA. BNP Paribas Exane lifted their price target on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Oppenheimer upped their price objective on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Rothschild & Co Redburn increased their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Finally, Barclays boosted their target price on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.90.

Corteva Price Performance

The company has a market capitalization of $57.74 billion, a PE ratio of 50.79, a price-to-earnings-growth ratio of 2.62 and a beta of 0.56. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock’s 50 day simple moving average is $79.80 and its 200-day simple moving average is $76.94.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Institutional Trading of Corteva

A number of large investors have recently modified their holdings of CTVA. Versant Capital Management Inc grew its stake in Corteva by 10.0% during the 2nd quarter. Versant Capital Management Inc now owns 4,580 shares of the company’s stock worth $388,000 after purchasing an additional 417 shares in the last quarter. Western Wealth Management LLC acquired a new stake in Corteva in the 1st quarter valued at about $142,000. Farmers National Bank acquired a new stake in Corteva in the 1st quarter valued at about $211,000. Midwest Financial Network LLC boosted its stake in shares of Corteva by 16.2% in the 1st quarter. Midwest Financial Network LLC now owns 4,687 shares of the company’s stock valued at $392,000 after buying an additional 653 shares during the period. Finally, DV Trading LLC purchased a new position in shares of Corteva in the 1st quarter valued at about $243,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.